These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy. Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638 [TBL] [Abstract][Full Text] [Related]
5. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. Jensen H; Zerouala C; Carrier M; Short B J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826 [TBL] [Abstract][Full Text] [Related]
6. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708 [TBL] [Abstract][Full Text] [Related]
7. Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis. Karicherla P; Hobden JA Curr Eye Res; 2010 Mar; 35(3):220-4. PubMed ID: 20373880 [TBL] [Abstract][Full Text] [Related]
8. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. Mannis MJ Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697 [TBL] [Abstract][Full Text] [Related]
9. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656 [TBL] [Abstract][Full Text] [Related]
11. Perineural infiltrates in Pseudomonas keratitis. Robbie SJ; Vega FA; Tint NL; Hau S; Allan B J Cataract Refract Surg; 2013 Nov; 39(11):1764-7. PubMed ID: 24160385 [TBL] [Abstract][Full Text] [Related]
12. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits. Shiao S; Isobe Y; Hatano H; Ohno S Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections. Ledbetter EC; Mun JJ; Kowbel D; Fleiszig SM Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):729-36. PubMed ID: 18836164 [TBL] [Abstract][Full Text] [Related]
14. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis. Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931 [TBL] [Abstract][Full Text] [Related]
15. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Alexandrakis G; Alfonso EC; Miller D Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897 [TBL] [Abstract][Full Text] [Related]
16. Multiresistant Pseudomonas keratitis. Ku JY; Kim P; Tong J; Wechsler A; McCluskey P Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829 [No Abstract] [Full Text] [Related]